Study to Evaluate the Efficacy and Safety of AMG 301 in Migraine Prevention

NCT03238781 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

343

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Migraine or Episodic Migraine

Interventions

DRUG: Placebo
DRUG: AMG 301

Sponsor

Amgen